SOLIGENIX, INC. Cash and Restricted Cash
SOLIGENIX, INC. (SNGX) had Cash and Restricted Cash of $9.81 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-07
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.81M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.03M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.94M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.53M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $9.81M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $6.03M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $7.94M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $10.53M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $5.10M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $7.30M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $7.82M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $9.84M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $9.41M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $7.09M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $8.45M 10-K · filed 2026-03-31 |
| 2023-09-30 | $10.30M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $13.16M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $10.27M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $13.36M 10-K · filed 2025-03-21 |
| 2022-09-30 | $16.87M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $20.16M 10-Q · filed 2023-08-21 |
| 2022-03-31 | $22.88M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $26.04M 10-K · filed 2024-03-15 |
| 2021-09-30 | $28.87M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $28.98M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $30.54M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $18.68M 10-K · filed 2023-03-31 |
| 2019-12-31 | $5.42M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |